Hypoglycemic News and Research

RSS

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.

28 Jul 2005

Glucose byproduct prevents brain damage after diabetic coma

A natural, non-toxic byproduct of glucose may prevent brain cell death and cognitive impairment in diabetics following an episode of severely low blood sugar, according to researchers at the San Francisco VA Medical Center (SFVAMC).

4 May 2005

Diabetes researchers look at pizza to find slow and steady insulin delivery wins the race

With its doughy, carbohydrate-dense crust and high fat content, pizza can wreak havoc in people with diabetes. A Penn State Diabetes Center study suggests a slow and steady insulin-dosing pattern may best combat the glucose-raising effects of that common favorite food.

3 May 2005

Natural glucose byproduct prevents brain damage and cognitive impairment after diabetic coma

27 Apr 2005

Diabetics who do not have good control over their blood sugar levels are more susceptible to oral health problems

Diabetes affects 18.2 million people in the United States and is expected to double by the year 2010. Additionally, diabetics who do not have good control over their blood sugar levels are more susceptible to oral health problems than non-diabetics

13 Dec 2004

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Research presented today showed that the investigational drug, LAF237, the first in a new class, improved glycemic control in patients with type 2 diabetes. In this study, LAF237, which is administered as a tablet to be taken orally, was added to the standard diabetes treatment metformin in patients whose diabetes was not adequately controlled by metformin alone.

7 Jun 2004

Side Effects of Diabetes Drugs Involve Unsuspected Brain Region

A brain region involved in emotional and intellectual processes appears to also play an unsuspected role in the body’s visceral response to dangerously low blood sugar levels, according to research at Washington University School of Medicine in St Louis. Low blood sugar, called hypoglycemia, is a common and dangerous side effect of drugs that control insulin levels in people with diabetes.

22 Mar 2004

Hypoglycemic News and Research

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Glucose byproduct prevents brain damage after diabetic coma

Diabetes researchers look at pizza to find slow and steady insulin delivery wins the race

Natural glucose byproduct prevents brain damage and cognitive impairment after diabetic coma

Diabetics who do not have good control over their blood sugar levels are more susceptible to oral health problems

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Side Effects of Diabetes Drugs Involve Unsuspected Brain Region

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest News